Breaks Categories: News

TuesdayJul 29, 2025 9:25 am

NetworkNewsBreaks – Branded Legacy, Inc. (OTC: BLEG) Signs LOI to Acquire Bio-Legacy Evaluative Group and Expand Intranasal Drug Delivery Portfolio

Branded Legacy (OTC: BLEG), a diversified holdings company focused on health and wellness solutions, announced the execution of a non-binding Letter of Intent to acquire Bio-Legacy Evaluative Group, a pioneer in advanced intranasal drug delivery technologies. The proposed $1.5 million Preferred D stock transaction would transfer 100% of Bio-Legacy’s equity, assets, and IP, supporting Branded Legacy’s entry into high-growth markets for addiction treatments and vaccine accessibility. Bio-Legacy’s patented naloxone device addresses cost and dosing challenges in a market projected to exceed $1.16 billion by 2032. Following the closing, Bio-Legacy CEO Amin Janmohamed will assume the roles of CEO and Chairman of…

Continue Reading

TuesdayJul 29, 2025 9:10 am

NetworkNewsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Drivers Deliver Strong Results at Laguna Seca

SEGG Media (NASDAQ: SEGG, LTRYW), a technology company at the intersection of sports, entertainment and gaming, showcased its Sports.com and Lottery.com brands during the Java House Grand Prix of Monterey at WeatherTech Raceway Laguna Seca. Callum Ilott surged from P24 to finish P6, marking PREMA Racing’s best-ever NTT INDYCAR Series result. Louis Foster qualified P7, maintaining his streak of top-10 starts, while Sebastian Murray rebounded from an early setback with a career-best fifth-place finish in INDY NXT by Firestone, earning top honors for the Andretti fleet. SEGG Media Chairman and CEO Matthew McGahan said the exposure underscored the value promised…

Continue Reading

TuesdayJul 29, 2025 9:00 am

NetworkNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Receives FDA Fast Track Designation for CLD-201 in Soft Tissue Sarcoma

Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company developing targeted genetic medicine delivery therapies, announced that the U.S. Food and Drug Administration granted Fast Track designation to CLD-201 (SuperNova), its allogeneic adipose stem-cell loaded oncolytic virus for treating soft tissue sarcoma. The designation provides opportunities for expedited development, including priority review and accelerated approval. CLD-201, which received IND clearance in April, will enter a Phase 1 trial evaluating safety and efficacy in sarcoma, triple-negative breast cancer, and head and neck squamous cell carcinoma. Chief Medical Officer Guy Travis Clifton, M.D., said the milestone validates CLD-201’s potential to deliver durable,…

Continue Reading

MondayJul 28, 2025 11:16 am

NetworkNewsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Showcases Drivers at Laguna Seca Java House Grand Prix of Monterey

SEGG Media (NASDAQ: SEGG, LTRYW), a technology company at the intersection of sports, entertainment and gaming, announced that Lottery.com and Sports.com-sponsored drivers Callum Ilott, Louis Foster and Sebastian Murray will compete at the Java House Grand Prix of Monterey at WeatherTech Raceway Laguna Seca. Foster, driving the #45 Droplight Honda for Rahal Letterman Lanigan Racing, enters the event with an average starting position of 8.4 over the last five races and aims to convert his strong qualifying pace into points. Ilott returns to the circuit where he secured his career-best IndyCar finish of P5 in 2023, while Murray makes his…

Continue Reading

MondayJul 28, 2025 11:00 am

NetworkNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Joins Exclusive Serie B Multi-Club Ownership Ranks, Juve Stabia Valuation Surges 245%

Brera Holdings (NASDAQ: BREA), an Ireland-based international holding company pursuing a multi-club ownership (MCO) strategy, has become the second MCO in Italy’s Serie B League alongside City Football Group, majority owned by Abu Dhabi United Group. Brera owns SS Juve Stabia, while City Group holds Palermo FC and Manchester City FC. Executive Chairman Daniel J. McClory said the Serie B owners’ meetings in Rome highlighted Brera’s integration into the league’s top ownership group. Juve Stabia, dubbed “The Second Team of Naples,” posted the highest market value increase in Serie B over the 2024-25 season, rising 245% to US$32 million from…

Continue Reading

MondayJul 28, 2025 10:58 am

NetworkNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Announces 1-for-12 Reverse Stock Split Effective August 5

Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company developing targeted genetic medicine delivery platforms, will implement a 1-for-12 reverse stock split of its common stock effective August 5, 2025. Shares will begin trading on a split-adjusted basis on the NYSE American under the existing ticker “CLDI,” with a new CUSIP of 320703 408. The reverse split, approved by shareholders on July 9 and ratified by the board on July 11, is intended to optimize market dynamics, expand investor appeal and align trading conditions with shareholder interests. Every 12 pre-split shares will convert into one post-split share, with fractional shares…

Continue Reading

MondayJul 28, 2025 10:45 am

NetworkNewsBreaks – Fifty 1 Labs, Inc. (OTC: FITY) to Host July 28 Virtual Shareholder Teleconference Featuring Nobel Laureate Dr. James Orbinski

Fifty 1 Labs (OTC: FITY), a leader in AI-powered health and wellness solutions, announced it will host a virtual shareholder teleconference on Monday, July 28, 2025, at 12:00 PM EST. The event, streamed live on X (formerly Twitter), will feature Senior Scientist Dr. James Orbinski, who accepted the 1999 Nobel Peace Prize on behalf of Médecins Sans Frontières (Doctors Without Borders). The teleconference will highlight the company’s strategic roadmap for subsidiary Fifty 1 AI Labs, including AI-driven drug repurposing for functional medicine, a $1 million R&D investment, and plans for a $5–10 million biotech acquisition by 2027. Management underscored alignment…

Continue Reading

MondayJul 28, 2025 10:34 am

NetworkNewsBreaks – HealthLynked Corp. (OTCQB: HLYK) Launches Enterprise Healthcare Solutions Website and Upgrades Provider Directory

HealthLynked (OTCQB: HLYK), a pioneer in healthcare technology and patient engagement, announced the launch of its newly designed Enterprise Healthcare Solutions Website, www.hlykgroup.com, and significant enhancements to its national provider directory. The new platform serves as a centralized hub for insurance carriers, pharmaceutical companies, marketing firms, ACOs, healthcare networks, and large employers, offering tools for patient engagement, population health, clinical research, coordinated care, and cost management. Upgrades to the consumer-facing provider directory include faster performance and localized provider suggestions, giving patients improved flexibility and transparency in selecting care. CEO Dr. Michael Dent said the developments reflect HealthLynked’s expanding role in…

Continue Reading

MondayJul 28, 2025 9:45 am

NetworkNewsBreaks – Bollinger Innovations, Inc. (NASDAQ: BINI) Completes Name and Ticker Change from Mullen Automotive

Bollinger Innovations (NASDAQ: BINI), an electric vehicle manufacturer, announced that its previously disclosed name change from Mullen Automotive Inc. to Bollinger Innovations, Inc. is effective as of July 28, 2025, along with its new Nasdaq stock symbol “BINI.” The company stated the transition unifies its commercial Class 1, 3 and 4 vehicles under a single brand identity. CEO and Chairman David Michery said the move marks the completion of the company’s brand evolution while having no impact on its legal structure or operations. No shareholder action is required as a result of the changes. To view the full press release,…

Continue Reading

MondayJul 28, 2025 9:00 am

NetworkNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Appoints Dr. Lee T. Schalop to Board to Bolster AI-Driven Precision Oncology

Lantern Pharma (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging artificial intelligence and genomic data to accelerate oncology drug discovery, announced the appointment of Lee T. Schalop, MD, to its Board of Directors. Dr. Schalop, co-founder and former CEO of Oncoceutics Inc., brings over 20 years of experience in biotechnology leadership and financial markets, with a track record in developing targeted therapies for solid tumors, including HK327M-mutant gliomas. Oncoceutics was acquired by Chimerix Inc. (NASDAQ: CMRX) for $450 million in 2021 and later by Jazz Pharmaceuticals for $935 million in April 2025. Lantern CEO Panna Sharma said Dr. Schalop’s expertise in…

Continue Reading